Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-00562271 |
| Trade Name | |
| Synonyms | PF-562271|PF-562,271|PF-271|VS-6062 |
| Drug Descriptions |
PF-00562271 is an ATP-competitive inhibitor of FAK and PYK2, which may result in inhibition of cell proliferation and migration, and reduce cell survival (PMID: 18339875, PMID: 23536552, PMID: 22454420). |
| DrugClasses | FAK inhibitor 16 |
| CAS Registry Number | 939791-38-5 |
| NCIT ID | C78199 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Docetaxel + PF-00562271 | Docetaxel PF-00562271 | 0 | 0 |
| PF-00562271 | PF-00562271 | 0 | 0 |